LifeArc appoints Dr Linda Bradley to head up business development

Dr Linda Bradley has joined as our new Head of Business Development, effective immediately.

KQ Labs announces the graduation of its third cohort in a highly successful Demo Day event

KQ Labs will be opening its next cohort for applications in early May 2021

LifeArc and Action Medical Research announce commitment of over £1m to research into rare diseases in children

Demonstrates our focus on improving the lives of people living with rare diseases.

LifeArc provides £5 million funding to increase understanding of the role of genetic risk factors in patient response to COVID-19

February 15, 2021: Medical research charity, LifeArc, announces today that it is providing £5 million funding to…

LifeArc invests £10 million in Illumina Accelerator to Advance Genomics Startups

London, February 8, 2021: LifeArc announced today a £10 million cornerstone investment in the funding cycle of…

LifeArc working with the Crohn’s & Colitis Foundation to develop a prognostic test for Crohn’s disease in children

A new partnership between LifeArc and the US-based Crohn’s & Colitis Foundation (Foundation) aims to progress encouraging…

Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration

Ongoing collaboration extended for another 12 months and successfully progresses into late stage hit-to-lead optimisation phase Cambridge…

LifeArc funds COVID-19 drug screening hub at the University of Glasgow

A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University…

LifeArc co-leads £6 million funding in DJS Antibodies

LifeArc announces Seed Fund investment of £2 million in DJS Antibodies, a biotech start-up company pioneering the…